Sort
21,281 grants matching “influenza”
A dual vaccine strategy against filovirus infection
$991,533Richard W Compans · Emory University · R01 · FY2012 · AI
Biomimetic Macrophage Membrane-Coated Nanosponges: A Novel Therapeutic for Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Hospital-Associated Pneumonia
$991,226Victor Nizet · University Of California, San Diego · R01 · FY2025 · AI
i-AKC: Integrated AIRR Knowledge Commons
$991,180Lindsay G. Cowell · Ut Southwestern Medical Center · U24 · FY2025 · AI
Clinic-Ready MACH-1 Gene Gun for delivery of a universal influenza DNA vaccine
$990,275Hannah Frizzell · Orlance, Inc. · R44 · FY2024 · AI
Ethical, Legal and Social Issues for Precision Medicine and Infectious Disease
$990,267Gail Geller · Johns Hopkins University · RM1 · FY2019 · HG
Role of intracellular organelle homeostasis in adaptation to dietary restrictive interventions
$990,208Michael Sack · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance
$989,476Sue Huang · Inst Of Environmental Science & Research · U01 · FY2011 · IP
Human Genetic Analysis Resource
$989,461Robert C. Elston · Case Western Reserve University · P41 · FY2009 · RR
Alterations In Pulmonary Immune Function And Host Resistance In COX Null Mice
$989,244Darryl C Zeldin · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES
Influenza Viral Genomics and Evolution
$989,136Jeffery Taubenberger · Niaid Extramural Activities · Z01 · FY2007 · AI
Vaccine and Treatment Evaluation Units (VTEU)
$989,030Hana M El Sahli · Baylor College Of Medicine · UM1 · FY2021 · AI
An RSV Prefusion F Vaccine that Overcomes Immunosenescence
$989,026Mark Yondola · Calder Biosciences, Inc. · R44 · FY2021 · AG
Human Genetic Analysis Resource
$988,394Robert C. Elston · Case Western Reserve University · P41 · FY2010 · RR
Monitoring of disease-induced skin VOC patterns from handheld and wearable chemical sensors
$988,302Cristina Elizabeth Davis · University Of California At Davis · U01 · FY2022 · TR
Integrated System for Rapid Detection of Respiratory Pathogens
$988,269Michael J Lochhead · Mbio Diagnostics, Inc. · R01 · FY2014 · AI
RFA-IP-22-004, US Platform to Measure Effectiveness of Seasonal Influenza, COVID-19 and other Respiratory Virus Vaccines for the Prevention of Acute Illness in Ambulatory Settings
$987,989Emmanuel B Walter · Duke University · U01 · FY2022 · IP
NIAID Centers of Excellence for Influenza Research and Response: Avian Influenza Research Activities
$987,930Scott Hensley · University Of Pennsylvania · N01 · FY2025 · AI
Antibody Neutralization Mechanisms
$987,511Peter D Kwong · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Strain-Independent Therapeutic Antibodies for Influenza
$987,301Lawrence Michael Kauvar · Trellis Bioscience, Inc. · R44 · FY2016 · AI
System for faster microarray assays and end-to-end workflow automation
$987,240Jay Kenneth Fisher · Redbud Labs, Inc. · R44 · FY2020 · GM
TASK A88: Ferret Model for Testing of Universal Influenza Vaccine Candidates
$986,910David Kelvin · University Health Network · N01 · FY2015 · AI
PANDAA for universal, pan-lineage molecular detection of Crimean-Congo Hemorrhagic Fever virus.
$986,903Iain James Macleod · Aldatu Biosciences, Inc. · R44 · FY2024 · AI
Maternal Immunity
$986,751Marcela F Pasetti · University Of Maryland Baltimore · U19 · FY2023 · AI
A Universal Flu Vaccine Based On Conformationally Locked Soluble Headless HA
$986,704Mark Yondola · Calder Biosciences, Inc. · R44 · FY2018 · AG
NIAID Centers of Excellence for Influenza Research and Response
$986,678Scott Hensley · University Of Pennsylvania · N01 · FY2024 · AI